GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senzime AB (STU:6YC) » Definitions » Cyclically Adjusted Price-to-FCF

Senzime AB (STU:6YC) Cyclically Adjusted Price-to-FCF : (As of Jun. 04, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Senzime AB Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Senzime AB Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Senzime AB's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senzime AB Cyclically Adjusted Price-to-FCF Chart

Senzime AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Senzime AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Senzime AB's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Senzime AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Senzime AB's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Senzime AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Senzime AB's Cyclically Adjusted Price-to-FCF falls into.


;
;

Senzime AB Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Senzime AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Senzime AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.026/132.8245*132.8245
=-0.026

Current CPI (Mar. 2025) = 132.8245.

Senzime AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.027 99.995 -0.036
201509 -0.013 100.228 -0.017
201512 -0.018 100.276 -0.024
201603 -0.016 100.751 -0.021
201606 -0.014 101.019 -0.018
201609 -0.016 101.138 -0.021
201612 -0.015 102.022 -0.020
201703 -0.018 102.022 -0.023
201706 -0.013 102.752 -0.017
201709 -0.015 103.279 -0.019
201712 -0.015 103.793 -0.019
201803 -0.015 103.962 -0.019
201806 -0.015 104.875 -0.019
201809 -0.016 105.679 -0.020
201812 -0.022 105.912 -0.028
201903 -0.023 105.886 -0.029
201906 -0.010 106.742 -0.012
201909 -0.010 107.214 -0.012
201912 -0.014 107.766 -0.017
202003 -0.011 106.563 -0.014
202006 -0.015 107.498 -0.019
202009 -0.013 107.635 -0.016
202012 -0.025 108.296 -0.031
202103 -0.028 108.360 -0.034
202106 -0.037 108.928 -0.045
202109 -0.032 110.338 -0.039
202112 -0.033 112.486 -0.039
202203 -0.028 114.825 -0.032
202206 -0.037 118.384 -0.042
202209 -0.090 122.296 -0.098
202212 -0.040 126.365 -0.042
202303 -0.043 127.042 -0.045
202306 -0.031 129.407 -0.032
202309 -0.023 130.224 -0.023
202312 -0.024 131.912 -0.024
202403 -0.024 132.205 -0.024
202406 -0.026 132.716 -0.026
202409 -0.021 132.304 -0.021
202412 -0.019 132.987 -0.019
202503 -0.026 132.825 -0.026

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Senzime AB  (STU:6YC) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Senzime AB Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Senzime AB's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Senzime AB Business Description

Traded in Other Exchanges
Address
Verkstadsgatan 8, Uppsala, SWE, 753 23
Senzime AB is a medical device company providing patient monitoring systems. Its portfolio comprises systems for patient monitoring of neuromuscular function and breathing, typically during and after surgery, and for the intensive care sector. TetraGraph is a system based on EMG technology for neuromuscular monitoring during surgical procedures. ExSpiron 2Xi is a non-invasive monitoring system of respiratory volume and minute ventilation used for in and out patient care. The company operates in Sweden, Germany and the USA. It derives revenue through sales of monitors and associated disposable sensors to hospitals and clinics.

Senzime AB Headlines

No Headlines